- Stressed and Distracted, Kids and Their Teachers Say Virtual Learning Isn’t Working
- Fauci Says U.S. Will Stay With Two Doses of Pfizer, Moderna Vaccines
- Health Highlights, March 2, 2021
- Many Blacks, Hispanics Believe They’ll Get Worse Care If Dementia Strikes
- For Some Young Drivers, Smartphone Use Is One of Many Bad Habits
- Strep Throat Doesn’t Worsen Tourette But May Affect ADHD: Study
- Sports Position Doesn’t Affect Risk of Concussion-Linked CTE Illness
- ‘Telestroke’ Care at Hospitals Is Boosting Patient Outcomes
- Face Masks Won’t Impede Your Breathing, Study Confirms
- Pot May Not Be the Best Rx for a Migraine
Clinical Trials Update: March 5, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Adolescent Migraine
This study will evaluate an investigational medication for chronic migraines in people aged 12 to 17.
The research site is in Mesa, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/migraine.aspx.
—–
Chronic Obstructive Pulmonary Disease (COPD)
This study will evaluate an investigational drug to treat symptoms of COPD. You must have been diagnosed with COPD and have had a flare in the past 12 months to qualify.
The research site is in Miami, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/copd.aspx.
—–
Alzheimer’s Disease
This study will evaluate the effectiveness of an investigational medication at slowing the impact of Alzheimer’s disease on memory and daily activities. Drug is given intravenously once every four weeks.
The research site is in Denver, Colo.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/alzheimer’s_disease.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
